Nicox Whistler Phase 3b Glaucoma Trial Results 01
May 16, 2025

Nicox’s NCX 470 Shows Dual IOP-Lowering Promise in Whistler Phase IIIb Trial

New data sheds light on how Nicox’s eye drop may improve outflow and reduce pressure—twice over. Nicox (Sophia Antipolis, France)…

Discover our fascinating content at issuu

explore